Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Mineralys Therapeutics Inc.
MLYS | US
27.51
USD-0.98
-3.44%
MLYS | US
Loading StockChartView...
About Mineralys Therapeutics Inc.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
27.51
Open
28.40
High
28.97
Low
27.26
Mineralys Therapeutics Inc. a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat a proprietary orally administered highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor Pennsylvania.
View LessMLYS | US
Risk
77.6
Sharpe
0.94
Luna's Score
46/100
Recommendation
Hold
Luna says (MLYS | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High Short-term Volatility
Smallcap (300M - 2B USD)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
66.0%1 month
77.6%3 months
62.4%6 months
62.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.47
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-7.41
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
1.37B
MarketCap(USD)
1.37B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-41.62
Short ratio
14.21
Short perc.
4.67
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
5.40
Range1M
8.18
Range3M
11.80
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.45
Price X volume
14.36M
